| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |